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Abstract
Background: Accumulating evidence suggests that breastfeeding benefits children’s in-
telligence, possibly due to long-chain polyunsaturated fatty acids (LC-PUFAs) present in
breast milk. Under a nutritional adequacy hypothesis, an interaction between breastfeed-
ing and genetic variants associated with endogenous LC-PUFAs synthesis might be
expected. However, the literature on this topic is controversial.
Methods: We investigated this gene  environment interaction through a collaborative
effort. The primary analysis involved >12 000 individuals and used ever breastfeeding,
FADS2 polymorphisms rs174575 and rs1535 coded assuming a recessive effect of the G
allele, and intelligence quotient (IQ) in Z scores.
Results: There was no strong evidence of interaction, with pooled covariate-adjusted in-
teraction coefficients (i.e. difference between genetic groups of the difference in IQ Z
scores comparing ever with never breastfed individuals) of 0.12[(95% confidence interval
(CI): 0.19; 0.43] and 0.06 (95% CI: 0.16; 0.27) for the rs174575 and rs1535 variants, re-
spectively. Secondary analyses corroborated these results. In studies with 5.85 and
<5.85months of breastfeeding duration, pooled estimates for the rs174575 variant were
0.50 (95% CI: 0.06; 1.06) and 0.14 (95% CI: 0.10; 0.38), respectively, and 0.27 (95% CI:
0.28; 0.82) and 0.01 (95% CI: 0.19; 0.16) for the rs1535 variant.
Conclusions: Our findings did not support an interaction between ever breastfeeding
and FADS2 polymorphisms. However, subgroup analysis suggested that breastfeeding
may supply LC-PUFAs requirements for cognitive development if breastfeeding lasts for
some (currently unknown) time. Future studies in large individual-level datasets would
allow properly powered subgroup analyses and further improve our understanding on
the breastfeeding  FADS2 interaction.
Key words: Breastfeeding, intelligence, FADS2, fatty acids, effect modification, meta-analysis
Key Messages
• Breastfeeding is considered to improve children’s intelligence, possibly due to long-chain polyunsaturated fatty acids
(LC-PUFAs).
• The literature on the interaction between breastfeeding and variants in the FADS2 on intelligence quotient (IQ) is
controversial.
• Our de novo collaborative meta-analysis did not find support for this interaction when comparing ever vs never
breastfed individuals.
• Subgroup analyses, although underpowered, were compatible with a role of breastfeeding duration in this interac-
tion. This finding requires replication.
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Introduction
Breastfeeding has well-established short-term benefits on
children’s health. There is also accumulating evidence that
breastfeeding may benefit cognitive development.1
A recent meta-analysis of observational studies reported
that breastfed subjects scored higher on intelligence quo-
tient (IQ) tests [mean difference 3.4 [95% confidence inter-
val (CI): 2.3; 4.6]} than non-breastfed subjects.2 Although
issues such as residual confounding3 and publication bias4
could have affected this estimate, randomized controlled
trials of breastfeeding promotion reported benefits in mo-
tor development in the first year of life5 and in IQ at
6.5 years of age.6 Additional studies corroborate the notion
that breastfeeding has a causal effect on IQ. These include
comparisons between cohorts with different confounding
structures,7 and comparisons between mothers who tried,
but could not breastfeed their child and mothers who had
formula feeding as their first choice.8
One of the possible biological mechanisms underlying
the effect of breastfeeding on IQ is through long-chain
polyunsaturated fatty acids (LC-PUFAs), such as docosa-
hexaenoic acid (DHA). Meta-analyses of randomized
controlled trials of supplementation of DHA and
other LC-PUFAs in infants reported improved cognitive
development9 and visual acuity.10 DHA is an important
component of the membrane of brain cells and retina
cells.11,12 Studies in animal models and humans
suggest that adequate levels of DHA are important
for cognitive development through several processes,
such as biogenesis and fluidity of cellular membranes,
neurogenesis, neurotransmission and protection against
oxidative stress.12,13
The role of LC-PUFAs in the association between
breastfeeding and IQ can be investigated through a gene 
environment (GE) interaction analysis. Here, we framed
this GE interaction as a nutritional adequacy hypothesis.
A brief and general definition of nutritional adequacy is
that, once an individual’s nutritional requirement is met,
further intake of the given nutrient yields no additional
benefit.14–16 This concept is important when defining die-
tary recommendations to improve nutrition and its down-
stream consequences, such as disease prevention.15,16 In
the case of the present study, our nutritional adequacy hy-
pothesis (Figure 1) postulates that there is an upper limit
for the benefits of increasing DHA levels (Figure 1, left
panel) and such requirements are met by pre-formed DHA
available in breast milk (Figure 1, right panel). In this case,
inter-individual variation in IQ due to genetically deter-
mined differences in DHA endogenous synthesis from met-
abolic precursors would only be observable in individuals
who were not breastfed.14 Therefore, the effect of breast-
feeding on intelligence would be stronger among carriers
of genotypes associated with lower DHA endogenous syn-
thesis compared with carriers of genotypes associated with
higher synthesis, because the first depend more on breast-
feeding to achieve optimal DHA levels for cognitive devel-
opment. Importantly, our nutritional adequacy hypothesis
postulates a weaker, but non-zero effect of breastfeeding
on intelligence among carriers of DHA-increasing geno-
types. because breastfeeding may act through many mecha-
nisms in addition to providing pre-formed DHA.1,17
This GE interaction has been investigated using single
nucleotide polymorphisms (SNPs) in the FADS2 gene.14,18–21
This gene encodes a desaturase enzyme that catalyzes a
Figure 1. Illustration of the nutritional adequacy hypothesis involving breastfeeding, LC-PUFAs levels and associated genotypes, and cognitive development.
Left panel: the benefits of increasing LC-PUFAs on cognitive development are assumed to exist only until a given level of LC-PUFAs (marked by T). Further in-
creasing LC-PUFAs above T brings no further cognitive benefits. Right panel: breastfeeding is assumed to provide LC-PUFA levels above T regardless of ge-
netic predisposition to higher or lower endogenous synthesis of LC-PUFAs. Non-breastfed individuals are assumed to need such genetic load of higher
endogenous synthesis to achieve T. LC-PUFAs: long-chain polyunsaturated fatty acids.
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rate-limiting reaction in the LC-PUFAs pathway.22,23
Candidate gene and genome-wide approaches reported
that minor alleles of SNPs in the FADS2 gene were associ-
ated with lower levels of PUFAs in plasma and erythrocyte
phospholipids.24–27 Caspi et al. were the first to evaluate
the interaction between genetic variation in FADS2 and
breastfeeding, with IQ in children as the outcome.18 Two
SNPs were evaluated: rs1535 (major/minor alleles: A/G)
and rs174575 (major/minor alleles: C/G). These SNPs are
in partial linkage disequilibrium, with an r2 metric ranging
from 0.33 to 0.68 in European populations in 1000
Genomes Phase 3. For both SNPs, having ever being
breastfed was positively associated with IQ in all genetic
groups, except in G-allele homozygotes where there was
no association.18 However, under the nutritional adequacy
hypothesis outlined above, G-allele homozygotes are the
subgroup expected to benefit the most from breastfeeding.
This result is not only inconsistent with our hypothesis,
but also with the notion that the benefits of breastfeeding
on IQ exist (perhaps with varying magnitudes) in most
population subgroups (in this case, genetically defined
subgroups).
However, in a replication study, Steer et al. presented
results consistent with our nutritional adequacy hypothe-
sis, with breastfed individuals presenting similar mean
values of IQ across FADS2 genotypes.14 Such values
were higher than those observed in never breastfed indi-
viduals, with the lowest value (and thus the greatest ef-
fect of breastfeeding) being in GG individuals.14 Morales
et al.28 reported that a negative association between gen-
otypes in other genetic variants related to lower activity
of enzymes involved in elongation and desaturation
processes and cognition, was only evident in non-
breastfed individuals. Three studies in twins (but not
twin studies, in the sense that they did not aim to esti-
mate heritability) did not detect strong evidence support-
ing this GE interaction.19–21
The contradictory results observed in the literature
may be due to lack of statistical power and/or contextual
differences that lead to heterogeneity between studies, as
discussed in detail elsewhere.29 In this study, we aimed at
improving the current understanding on this GE inter-
action and gaining insights into the sources of heteroge-
neity between studies through a consortium-based
initiative.29 Specifically, we addressed three research
questions: (i) is breastfeeding positively associated with
IQ in both subgroups of FADS2 genotypes (i.e. G-allele
homozygotes and others)?; (ii) is the association of
breastfeeding with IQ different between subgroups of
FADS2 genotypes (i.e. is there a GE interaction)?; and
(iii) do study-level characteristics explain between-study
heterogeneity in this GE interaction?
Methods
Overview of the study protocol
The protocol of this study has been published elsewhere.29
Briefly, studies that were known by the coordinating team
to have at least some of the data required, as well as other
studies suggested by collaborators, were invited to partici-
pate. All studies that were contacted (and were eligible)
accepted participation.
Eligibility criteria were: (i) availability of at least a
binary breastfeeding variable (i.e. whether or not the study
individuals were ever breastfed), intelligence measured
using standard tests and at least rs174575 or rs1535 SNPs
(either genotyped or imputed); and (ii) European ancestry
studies, or multi-ethnic studies capable of defining a sub-
sample of European ancestry individuals. Exclusion criteria
were: (i) only poorly imputed genetic data available (metrics
of imputation such as r2 or INFO quality below 0.3); (ii)
twin studies; and (iii) lack of appropriate ethical approval.
Statistical analysis was performed locally by data analysts
of the collaborating studies. Standardized analysis scripts
written in R [http://www.r-project.org/] were prepared cen-
trally and distributed to the analysts, along with a detailed
analysis plan. The scripts automatically generated files con-
taining summary descriptive and association statistics, which
were centrally meta-analysed. As the study progressed, some
modifications in the original protocol were required. These
are described in detail in Supplementary Methods, available
as Supplementary data at IJE online.
Participating studies
A total of 10 eligible studies were identified, all of which
were included in the meta-analysis: the 1982 Pelotas Birth
Cohort Study,30,31 Dunedin Multidisciplinary Health and
Development Study,18 Avon Longitudinal Study of Parents
and Children (ALSPAC),32 Copenhagen Prospective Study
on Asthma in Childhood (COPSAC) 2010,33,34 Generation
R Study,35–37 INfancia y Medio Ambiente (INMA)
Project,38 Western Australian Pregnancy Cohort (Raine)
Study,39–41 Sma˚børn Kost Og Trivsel-I (SKOT-I),42,43
SKOT-II44,45 and Saguenay Youth Study (SYS).46,47
In an attempt to improve statistical power, a subsample of
32 842 individuals from the UK Biobank48 was
included. These individuals had data on ever being breastfeed,
intelligence measures and genetic data. However, this sub-
sample did not fulfil the pre-established eligibility criteria be-
cause IQ was not measured using a standard test. Therefore,
these data were used in secondary analyses only, and analyses
including these data are clearly indicated as such. Information
about the participating studies is shown in Supplementary
Tables 1–3, available as Supplementary data at IJE online.
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Statistical analyses
The main outcome variable was IQ. IQ tests varied between
studies (Supplementary Table 1, available as Supplementary
data at IJE online). IQ measures were converted to Z scores
(mean¼0 and variance¼ 1) within each participating
study. The primary analysis involved breastfeeding (coded
as never¼0 and ever¼ 1), FADS2 polymorphism assuming
a recessive genetic effect of the G allele (i.e. GG individu-
als¼ 1; heterozygotes and non-G allele homozygotes¼0)
and an interaction term between them. Different genetic
effects, different categorizations of breastfeeding, and exclu-
sive breastfeeding (defined as receiving only breast milk and
no other food or drink, including water) were evaluated in
pre-planned secondary analyses. Unless explicitly stated, all
analyses refer to any quality of breastfeeding (i.e. combining
exclusive and non-exclusive breastfeeding).
Three analysis models were performed: (i) unadjusted (i.e.
no covariates); (ii) adjusted 1: controlling for sex and age (lin-
ear and quadratic terms) when IQ was measured, ancestry-
informative principal components (when available) and geno-
typing centre (for studies involving multiple laboratories); (iii)
adjusted 2: same covariates in adjusted 1 model, as well as
maternal education (linear and quadratic terms) and maternal
cognition (linear and quadratic terms); if only one of the ma-
ternal variables was available, adjusted model 2 controlled
only for that variable. Continuous covariates, as well as sex
(which was coded as male¼0 and female¼ 1), were mean-
centred before analysis, and squaring was performed before
mean-centring. Covariate adjustment was performed by in-
cluding not only a ‘main effect’ term, but also FADS2  co-
variate and breastfeeding covariate interaction terms.49
As a sensitivity analysis, the role of gene-environment
correlation was evaluated by repeating models (i) and (ii),
but having maternal cognition (in Z scores) or maternal
schooling (in years) as outcome variables rather than the
participant’s IQ. Maternal cognition or schooling are im-
portant predictors of an individual’s IQ, and cannot be
consequences of the participant’s genotype. Therefore, any
evidence of breastfeeding  FADS2 interaction in this
analysis is indicative that those maternal variables may
confound the main breastfeeding  FADS2 interaction
analysis having participant’s IQ as the outcome variable.
This is a form of negative control analysis.50
Analyses were performed using linear regression with
heteroskedasticity-robust standard errors. Results from all
studies were pooled using fixed and random effects meta-
analysis. Stratified meta-analysis and random effects meta-
regression were used to evaluate the potential moderating
role of the following variables (one meta-regression model
per moderator): IQ test; adjustment for ancestry-
informative principal components; age at IQ measurement;
timing of breastfeeding measurement; continental region;
mean year of birth; prevalence of having ever being
breastfed; mean breastfeeding duration; and sample size.
Adjusted R2 values, which can be interpreted as the amount
of between-study heterogeneity explained by the moderator,
were obtained from the meta-regression models.
The power of our primary analysis, focusing on the
rs174575 polymorphism, was quantified via simulations (see
the Supplementary Material, available as Supplementary data
at IJE online, for details). This complements the sample size
calculations presented in the protocol by allowing inclusion of
estimated between-study heterogeneity in the calculations.
Results
Characteristics of participating studies
As shown in Supplementary Table 1, available as
Supplementary data at IJE online, seven out of the 10 eligible
studies were conducted in Europe, four were population-based
and two were multi-ethnic. The average year of birth ranged
from 1972 to 2011. Three studies measured breastfeeding pro-
spectively, and four studies (two in children and two in adults)
measured IQ using the Wechsler Intelligence Scale.
Supplementary Table 2, available as Supplementary data
at IJE online, provides a description of the two FADS2 SNPs
in each study. The SNPs rs174575 and rs1535 were directly
genotyped in three and five studies, respectively. The mini-
mum value of imputation quality was 0.984. The frequency
of the G allele ranged from 20.5% to 30.8% for the
rs174575 variant, and from 28.5% to 39.1% for the rs1535
variant. There was no strong statistical evidence against
Hardy-Weinberg equilibrium, with the smallest P-values be-
ing 0.058 (Generation R) and 0.074 (SKOTI-II) for
rs174575, and 0.085 (1982 Pelotas Birth Cohort), 0.044
(Raine) and 0.089 (SKOTI-II) for rs1535. Although these
results may be suggestive of some population substructure
(especially in Generation R and in the 1982 Pelotas Birth
Cohort, which are multi-ethnic studies) or batch effects (espe-
cially in SKOTI-II, which is a combination of two indepen-
dent studies), it is unlikely that such phenomena substantially
influenced the results because ancestry-informative principal
components, computed using genome-wide genotyping data,
were adjusted for in these four studies.
Additional study characteristics are displayed in
Supplementary Table 3, available as Supplementary data at
IJE online. Among eligible studies (i.e. excluding the UK
Biobank), the mean age, maternal education and breastfeeding
duration ranged from 2.5 to 30.2 years, 11 to 19 years and 2.3
to 8.2 months, respectively. Each sex represented approxi-
mately half of the participants in all studies. All IQ measures
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produced a variable with mean close to 100 and similar stan-
dard deviations (median: 12.2; range: 9.6 to 16.3). The excep-
tion was the one used in SKOT-I and SKOT-II (i.e. third
edition of the Ages and Stages Questionnaire), which pro-
duced a variable with mean close to 50. The median of the
prevalence of ever breastfeeding was 91% (ranging from 50%
to 95%), and the median of the median of any breastfeeding
duration was 4.3 months (ranging from 0 to 7.9). Among all
individuals included in primary analysis for at least one of the
SNPs (n¼13 292), 11 055 were ever breastfed.
Primary analysis
In analyses without stratification according to FADS2 ge-
notype, ever breastfeeding was associated with increases of
0.37 (95% CI: 0.32; 0.42) and 0.30 (95% CI: 0.20; 0.40)
Z scores in IQ in fixed and random effects meta-analyses,
respectively. Assuming that IQ has a standard deviation
(SD) of 12.2 points (the median of the standard deviation
of IQ measures among participating studies), these coeffi-
cients correspond to 4.5 and 3.7 points in IQ, respectively.
In the fully adjusted model (adjusted 2), the respective
coefficients were 0.26 (95% CI: 0.21; 0.32) and 0.17
(95% CI: 0.03; 0.32), or 3.2 and 2.1 points in IQ.
Table 1 and Figure 2 display the results of the
primary analysis. There was considerable between-study
heterogeneity. Among non-G carries for the rs174575
SNP, pooled random effects estimates of mean differences
in IQ Z scores according to breastfeeding (ever¼ 1; never-
¼ 0) were 0.29 (95% CI: 0.17; 0.40) and 0.15 (95% CI:
0.00; 0.31) in the unadjusted and fully-adjusted models, re-
spectively. Among GG individuals, the respective estimates
were 0.43 (95% CI: 0.16; 0.70) and 0.31 (95% CI: 0.05;
0.58). There was no strong evidence of interaction, with
pooled estimates of the breastfeeding  FADS2 interaction
term of 0.18 (95% CI: 0.18; 0.54) and 0.12 (95% CI:
0.19; 0.43), respectively. These coefficients can be inter-
preted as the mean difference in IQ Z scores comparing
ever with never breastfed individuals among GG carriers,
minus the mean difference in IQ Z scores comparing ever
with never breastfed individuals among carriers of other
genotypes—e.g. a positive interaction coefficient indicates
that the benefit of breastfeeding on IQ is stronger among
GG individuals. Similar results were obtained when using
fixed effects meta-analysis.
Results for the rs1535 variant presented a similar trend,
but were even less suggestive of interaction. When using
random effects meta-analysis, the estimates of the interac-
tion term were 0.04 (95% CI: 0.24; 0.15) in the unad-
justed and 0.06 (95% CI: 0.16; 0.27) in the fully-
adjusted model (i.e. adjusted model 2). Using fixed effects
meta-analysis yielded similar results.
Table 1. Meta-analytical linear regression coefficients (b) of cognitive measures (in standard deviation units) according to
breastfeeding (never¼ 0; ever¼ 1), within strata of FADS2 rs174575 or rs1513 genotypes (recessive effect)
SNP Coefficient Model Number of Fixed effects meta-analysis Random effects meta-analysis
Estimates Subjects b 95% CI P-value b 95% CI P-value I2 (%)
rs174575 b in C-allele Unadjusted 8 11 741 0.37 0.32; 0.41 8.61050 0.29 0.17; 0.40 7.6107 76.4
carriers Adjusted (1)a 8 11 719 0.37 0.32; 0.42 7.71048 0.29 0.18; 0.41 7.9107 74.2
Adjusted (2)b 8 11 241 0.25 0.20; 0.31 6.41020 0.15 0.00; 0.31 0.055 84.1
b in GG Unadjusted 8 873 0.43 0.28; 0.58 3.8108 0.43 0.16; 0.70 0.002 64.4
individuals Adjusted (1)a 8 871 0.39 0.23; 0.54 9.3107 0.35 0.04; 0.65 0.024 67.2
Adjusted (2)b 8 836 0.34 0.17; 0.51 6.4105 0.31 0.05; 0.58 0.020 47.4
GE Unadjusted 8 12 614 0.11 0.05; 0.27 0.188 0.18 0.18; 0.54 0.323 77.6
Adjusted (1)a 8 12 590 0.04 0.12; 0.21 0.603 0.07 0.29; 0.43 0.705 75.5
Adjusted (2)b 8 12 077 0.10 0.07; 0.28 0.244 0.12 0.19; 0.43 0.445 59.5
rs1535 b in A-allele Unadjusted 9 11 690 0.37 0.32; 0.42 9.21049 0.29 0.18; 0.40 4.6107 73.5
carriers Adjusted (1)a 9 11 666 0.37 0.32; 0.42 9.91047 0.29 0.16; 0.42 7.1106 76.0
Adjusted (2)b 9 11 186 0.26 0.20; 0.31 1.91019 0.15 0.01; 0.32 0.065 84.0
b in GG Unadjusted 9 1512 0.29 0.17; 0.41 2.2106 0.24 0.05; 0.43 0.013 54.1
individuals Adjusted (1)a 9 1509 0.33 0.20; 0.45 2.2107 0.27 0.08; 0.47 5.4103 47.7
Adjusted (2)b 9 1447 0.28 0.16; 0.41 1.2105 0.25 0.09; 0.41 0.003 25.9
GE Unadjusted 9 13 202 0.03 0.16; 0.10 0.663 0.04 0.24; 0.15 0.646 42.6
Adjusted (1)a 9 13 175 0.02 0.16; 0.11 0.720 0.03 0.28; 0.21 0.778 60.9
Adjusted (2)b 9 12 633 0.07 0.06; 0.21 0.277 0.06 0.16; 0.27 0.592 49.6
GxE, interaction between breastfeeding and polymorphisms in the FADS2 gene; nestimates, number of estimates being pooled; nsubjects, pooled sample size.
aCovariates were sex, age (linear and quadratic terms), ancestry-informative principal components (if available) and genotyping centre (if necessary).
bSame covariates as in the adjusted (1) model, in addition to maternal education (linear and quadratic terms) and/or maternal cognition (linear and quadratic terms).
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Secondary analysis
As shown in Table 2 and Supplementary Tables 4–6, avail-
able as Supplementary data at IJE online, there was no
strong indication of interaction when analysing other cate-
gorizations of breastfeeding duration and FADS2 SNPs
coded assuming a recessive effect. This was also the case
when FADS2 variants were coded assuming additive
(Supplementary Table 7, available as Supplementary data
at IJE online), dominant (Supplementary Table 8, available
as Supplementary data at IJE online) and overdominant
(Supplementary Table 9, available as Supplementary data
at IJE online) effects. The same was observed for exclusive
breastfeeding (Supplementary Tables 10–13, available as
Supplementary data at IJE online).
Supplementary Table 14, available as Supplementary
data at IJE online, displays the results obtained when in-
cluding the UK Biobank, which was analysed as two inde-
pendent samples according to the genotyping platform
(Biobank_Axiom and Biobank_BiLEVE). Its inclusion
resulted in a combined sample size of more than 45 000
Figure 2. Forest plots of the GE interaction coefficientsa from the fully-adjustedb primary analysis (FADS2 variants coded in recessive form, and
breastfeeding categorized into ever x never breastfeeding) based on random effects meta-analysis.
SKOT-I and SKOT-II were excluded from the analyses for the rs174575 polymorphism because the model did not fit (due to a combination of modest
sample size, high prevalence of breastfeeding and assuming a recessive genetic effect of the rarest allele). 1982Pelotas, 1982 Pelotas Birth Cohort;
ALSPAC, Avon Longitudinal Study of Parents and Children; COPSAC2010, Copenhagen Prospective Study on Asthma in Childhood 2010; DMHDS,
Dunedin Multidisciplinary Health and Development Study; GenerationR, Generation R Study; INMA, INfancia y Medio Ambiente [Environment and
Childhood]; Raine, Western Australian Pregnancy Cohort (Raine) Study; SKOT-I and II, Sma˚børn Kost Og Trivsel (I and II); SYS, Saguenay Youth
Study. aThese coefficients can be interpreted as the mean difference in IQ Z scores comparing ever with never breastfed individuals among GG car-
riers minus the mean difference in IQ Z scores comparing ever with never breastfed individuals among carriers of other genotypes. bCovariates were
sex, age (linear and quadratic terms), ancestry-informative principal components (if available), genotyping centre (if necessary), maternal education
(linear and quadratic terms) and/or maternal cognition (linear and quadratic terms).
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individuals. When FADS2 variants were coded assuming
recessive effects, the pooled estimates from the unadjusted
model were 0.02 (95% CI: 0.10; 0.06) and 0.08 (95%
CI: 0.13; 0.29) for fixed and random effects meta-
analysis, respectively. The corresponding estimates from
the adjusted (1) model were 0.04 (95% CI: 0.13; 0.04)
and 0.00 (95% CI: 0.21; 0.20), respectively. There was
also no strong statistical evidence supporting an interaction
when other genetic effects were assumed.
Sensitivity analysis and power calculation
Table 3 displays the results of random effects meta-
regression. Neither type of IQ test, timing of breastfeeding
measurement, continental region nor mean year of birth
explained a substantial amount of between-study heteroge-
neity. For the rs174575 variant, the adjusted R2 of
ancestry-informative principal components was 88.0%,
with pooled estimates of 0.28 (95% CI: 0.02; 0.54) and
0.38 (95% CI: 0.72; 0.04) Z scores in IQ from studies
that did and did not adjust for principal components, re-
spectively, which would be suggestive of confounding due
to population stratification towards a negative association.
Age at IQ measurement was inversely associated with the
magnitude of the interaction term, with pooled estimates
of 0.06 (95% CI: 0.46; 0.58) and 0.20 (95% CI: 0.18;
0.58) when IQ was measured at 10 years of age or more,
or before that age, respectively, possibly suggesting an at-
tenuation of the effect over time. The adjusted R2 was
10.4% when entering age as a continuous variable, but
0% when dichotomized. When stratifying studies accord-
ing to prevalence of ever breastfeeding, the pooled estimate
among studies with a prevalence 90% was 0.36 (95%
CI: 0.19; 0.90), and 0.04 (95% CI: 0.38; 0.29) when
pooling the remaining studies. Adjusted R2 estimates were
16.4% and 72.3% when prevalence of ever breastfeeding
was analysed as a binary and as a continuous variable, re-
spectively. Among studies with breastfeeding duration
equal to or greater than the median among studies (i.e.
5.85 months), the pooled estimate was 0.50 (95% CI:
0.06; 1.06), compared with 0.14 (95% CI: 0.10; 0.38)
when pooling the remaining studies. The adjusted R2 was
45.5% when breastfeeding duration was dichotomized at
the median, but 0% when analysed continuously. When
stratifying studies into larger (1000 individuals) and
smaller (<1000 individuals), the pooled estimates were
0.26 (95% CI: 0.00; 0.52) and 0.03 (95% CI: 0.63;
0.56), with an adjusted R2 of 33.8% when sample size
was dichotomized, and of 0% when analysed in continu-
ous form.
Table 2. Meta-analytical linear regression coefficients (b) of the interaction term between FADS2 rs174575 or rs1535 genotypes
(recessive effect) with breastfeeding (<6months vs 6months, in ordinal categories or in months), having cognitive measures
(in standard deviation units) as the outcome
SNP Breastfeeding Model Number of Fixed effects meta-analysis Random effects meta-analysis
categorization Estimates Subjects b 95% CI P-value b 95% CI P-value I2 (%)
rs174575 <6 months ¼ 0 Unadjusted 8 11 733 0.05 0.10; 0.20 0.515 0.04 0.14; 0.22 0.647 23.1
6 months ¼ 1 Adjusted (1)a 8 11 706 0.07 0.09; 0.23 0.378 0.08 0.18; 0.35 0.546 53.6
Adjusted (2)b 8 11 242 0.10 0.07; 0.26 0.244 0.17 0.32; 0.65 0.496 82.6
Numerically- Unadjusted 8 11 733 0.04 0.01; 0.09 0.104 0.06 0.02; 0.15 0.150 57.1
coded duration Adjusted (1)a 8 11 706 0.04 0.02; 0.09 0.189 0.06 0.05; 0.16 0.282 58.7
categories Adjusted (2)b 8 11 242 0.04 0.01; 0.10 0.132 0.09 0.09; 0.26 0.346 84.6
Duration, in Unadjusted 8 11 733 0.01 0.01; 0.02 0.371 0.01 0.01; 0.03 0.335 13.9
months Adjusted (1)a 8 11 706 0.00 0.01; 0.02 0.608 0.01 0.02; 0.04 0.635 63.3
Adjusted (2)b 8 11 242 0.00 0.01; 0.02 0.782 0.01 0.04; 0.07 0.602 85.3
rs1535 <6 months ¼ 0 Unadjusted 8 12 018 0.05 0.17; 0.08 0.460 0.05 0.17; 0.08 0.460 0.0
6 months ¼ 1 Adjusted (1)a 8 11 991 0.07 0.20; 0.05 0.248 0.07 0.20; 0.06 0.302 8.0
Adjusted (2)b 8 11 499 0.08 0.21; 0.04 0.194 0.08 0.21; 0.05 0.216 3.9
Numerically- Unadjusted 8 12 018 0.00 0.04; 0.04 0.966 0.00 0.04; 0.04 0.966 0.0
coded duration Adjusted (1)a 8 11 991 0.01 0.06; 0.03 0.508 0.02 0.09; 0.05 0.635 54.3
categories Adjusted (2)b 8 11 499 0.01 0.05; 0.03 0.675 0.01 0.07; 0.05 0.728 29.9
Duration, in Unadjusted 8 12 018 0.00 0.01; 0.01 0.805 0.00 0.01; 0.01 0.805 0.0
months Adjusted (1)a 8 11 991 0.00 0.01; 0.01 0.538 0.01 0.03; 0.01 0.330 59.6
Adjusted (2)b 8 11 499 0.01 0.02; 0.01 0.320 0.01 0.02; 0.01 0.344 35.5
nestimates, number of estimates being pooled; nsubjects, pooled sample size.
aCovariates were sex, age (linear and quadratic terms), ancestry-informative principal components (if available) and genotyping centre (if necessary).
bSame covariates than in the adjusted (1) model, in addition to maternal education (linear and quadratic terms) and/or maternal cognition (linear and quadratic
terms).
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Regarding the rs1535 variant, the following subgroup-
specific estimates were consistent with those of the
rs174575 SNP: adjustment for principal components, with
pooled estimates of 0.09 (95% CI: 0.19; 0.37) and 0.03
(95% CI: 0.32; 0.25) among studies that did and did not
perform this adjustment, respectively; age at IQ measure-
ment, with pooled estimates of 0.04 (95% CI: 0.19;
0.37) and 0.07 (95% CI: 0.31; 0.45) among studies that
measured IQ when individuals were 10 and <10 years
old, respectively; and sample size, with pooled estimates of
0.11 (95% CI: 0.12; 0.34) and 0.01 (95% CI: 0.43 and
0.45) among larger and smaller studies, respectively.
However, in all those cases the adjusted R2 values were
0%. Prevalence of ever breastfeeding presented adjusted
R2 values of 0% and 8.3% when dichotomized and when
analysed continuously, respectively. The pooled estimates
for the rs1535 variant were 0.15 (95% CI: 0.31; 0.62)
and 0.01 (95% CI: 0.15; 0.18) among studies with preva-
lences of ever breastfeeding of 90% and <90%, respec-
tively. The most consistent moderator between SNPs was
breastfeeding duration, with pooled estimates for the
rs1535 SNP of 0.27 (95% CI: 0.28; 0.82) and 0.01
(95% CI: 0.19; 0.16) among studies with 5.85 and
<5.85 months of average duration, respectively; adjusted
R2 values were 22.2% and 4.9% when breastfeeding dura-
tion was dichotomized and analysed continuously,
respectively.
There was no strong evidence in support of gene-
environment correlation involving maternal education or
maternal cognition (Table 4). Regarding the rs174575 var-
iant, random effects meta-analytical estimates from the ad-
justed model were 0.16 (95% CI: 0.45; 0.78) for
maternal education, and 0.02 (95% CI: 0.25; 0.21) for
maternal cognition, respectively. The corresponding esti-
mates for the rs1535 SNP were 0.12 (95% CI: 0.51;
0.27) and 0.14 (95% CI: 0.04; 0.33).
Supplementary Table 15, available as Supplementary
data at IJE online, displays the results of the power calcu-
lations. Assuming no between-study heterogeneity, the
power of the primary analysis was 80% to detect a GE
coefficient between 0.219 and 0.263 IQ Z scores (with the
latter corresponding to the point estimate reported by Steer
et al.,14 which is the largest previous study on this topic)
using fixed effects meta-analysis. The random effects
model was similarly powered to detect GE coefficients
between 0.263 and 0.307. Assuming a between-study
Table 3. Stratified random effects meta-analytical linear regression coefficients (b) of the interaction term between FADS2
rs174575 or rs1535 genotypes (recessive effect) with breastfeeding (never¼0; ever¼1), having cognitive measures (in standard
deviation units) as the outcome. Estimates from the fully adjusted model were used
Analysis Categories rs174575 (CC or CG¼0; GG¼1) rs1535 (AA or AG¼0; GG¼1)
stratified by nestimates b (95% CI) P-value Adjusted nestimates b (95% CI) P-value Adjusted
(nsubjects) R
2 (%) (nsubjects) R
2 (%)
IQ test Wechslera 8055 (4) 0.12 (0.32; 0.56) 0.591 0.0 8070 (4) 0.09 (0.14; 0.32) 0.452 0.0
Other 4022 (4) 0.12 (0.37; 0.61) 0.631 4563 (5) 0.02 (0.45; 0.49) 0.932
Adjustment Yes 10 441 (6) 0.28 (0.02; 0.54) 0.036 88.0 10753 (7) 0.09 (0.19; 0.37) 0.531 0.0
for PCs No 1636 (2) 0.38 (0.72; 0.04) 0.028 1880 (2) 0.03 (0.32; 0.25) 0.814
Age at IQ 10 years 4373 (4) 0.06 (0.46; 0.58) 0.825 0.0b; 10.4c 4374 (4) 0.04 (0.25; 0.34) 0.773 0.0b; 0.0c
measurement <10 years 7704 (4) 0.20 (0.18; 0.58) 0.304 8259 (5) 0.07 (0.31; 0.45) 0.700
BF measurement Prospective 6912 (3) 0.27 (0.10; 0.63) 0.155 0.0 6926 (3) 0.20 (0.25; 0.64) 0.383 0.0
Retrospective 5165 (5) 0.01 (0.48; 0.47) 0.979 5707 (6) 0.01 (0.28; 0.27) 0.951
Continental Europe 7704 (4) 0.20 (0.18; 0.58) 0.304 0.0 8259 (5) 0.07 (0.31; 0.45) 0.700 0.0
region Other 4373 (4) 0.06 (0.46; 0.58) 0.825 4374 (4) 0.04 (0.25; 0.34) 0.773
Mean year of 2000 3002 (3) 0.20 (0.58; 0.98) 0.616 0.0b; 2.9c 3543 (4) 0.03 (0.62; 0.69) 0.917 0.0b; 0.0c
birth <2000 9075 (5) 0.10 (0.27; 0.46) 0.601 9090 (5) 0.07 (0.13; 0.27) 0.469
Prevalence of 90 4798 (4) 0.36 (0.19; 0.90) 0.200 16.4b; 72.3c 5339 (5) 0.15 (0.31; 0.62) 0.519 0.0b; 8.3c
any BF (%) <90 7279 (4) 0.04 (0.38; 0.29) 0.803 7294 (4) 0.01 (0.15; 0.18) 0.869
Duration of any 5.85 3367 (3) 0.50 (0.06; 1.06) 0.081 45.5b; 0.0c 3665 (4) 0.27 (0.28; 0.82) 0.333 22.2b; 4.9c
BF (months) <5.85 7866 (4) 0.14 (0.10; 0.38) 0.255 8123 (4) 0.01 (0.19; 0.16) 0.882
Sample size (n) 1000 9177 (4) 0.26 (0.00; 0.52) 0.052 33.8b; 0.0c 9191 (4) 0.11 (0.12; 0.34) 0.365 0.0b; 0.0c
<1000 2900 (4) 0.03 (0.63; 0.56) 0.910 3442 (5) 0.01 (0.43; 0.45) 0.974
PCs, ancestry-informative genetic principal components; BF, breastfeeding; nestimates, number of estimates being pooled; nsubjects: pooled sample size.
aIncludes both Wechsler Adult Intelligence Scale (ALSPAC and Dunedin Multidisciplinary Health and Development Study) and Wechsler Intelligence Scale for
Children (1982 Pelotas Birth Cohort and Saguenay Youth Study).
bVariable categorized as shown in the table.
cVariable entered in continuous form (e.g. age at outcome measurement modelled in years, as a continuous variable).
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variance of 0.103 (which was the observed between-study
heterogeneity in our meta-analysis), the fixed effects model
had 80% of power to detect GE coefficients between
0.307 and 0.351, whereas the random effects model was
similarly powered for coefficients between 0.439 and
0.483. Of note, in all cases power to detect our point
GE estimate of 0.121 was <50%.
Discussion
In this study, we assessed the hypothesis that FADS2 poly-
morphisms modify the association between breastfeeding
and IQ, as predicted by a nutritional adequacy hypothesis
(Figure 1). Our primary analyses were not supportive of
this interaction. This was also the case in a priori second-
ary analyses using different categorizations of breastfeed-
ing, exclusive rather than any quality of breastfeeding,
assuming different genetic effects and including a large
study that did not meet all eligibility criteria. Sensitivity
analyses were not supportive that gene-environment corre-
lation involving maternal education or maternal cognition
substantially influenced the results. Random effects meta-
regression suggested that breastfeeding duration was an
important moderator.
Results from our primary and secondary analyses were
not supportive of the nutritional adequacy hypothesis,
according to which a positive interaction coefficient would
be expected.14 In other words, there might be no upper
limit (or it may be very high) of the effects of LC-PUFAs on
IQ, so that supplementing infants with LC-PUFAs could be
beneficial for cognition for both lactating and non-
lactating infants alike. Importantly, this does not imply
that LC-PUFAs supplementation completely replaces the
benefits of breastfeeding, since the latter may act through
diverse mechanisms, and also provide benefits other than
for intelligence.1,17 Importantly, the absence of strong evi-
dence of GE interaction corroborates the notion that
there are cognitive benefits of breastfeeding in both genetic
subgroups of FADS2 genotypes, which were also seen in
the primary analysis (which were stratified on genotype).
This finding is against the notion that there is a FADS2 ge-
netic subgroup where breastfeeding is not associated with
IQ (which was one of the findings of the first study on this
GE interaction18) and is in accordance with the notion
that breastfeeding is beneficial to most population
subgroups.
On the other hand, in our random effects meta-
regression analysis, studies with longer average breastfeed-
ing duration generally presented interaction coefficients
that were positive and stronger in magnitude than studies
with shorter breastfeeding duration. Moreover, average
breastfeeding duration was the most consistent moderator
between polymorphisms (Table 3). Considering that
positive interaction coefficients are expected under the
nutritional adequacy hypothesis, this result raises the possi-
bility that there may be an upper limit of the benefits of
LC-PUFAs, but achieving such limits from breast milk
requires that breastfeeding lasts for some currently un-
known time. Given that breastfeeding practices in the par-
ticipating studies were generally well below international
recommendations,51,52 it is possible that the amount of
LC-PUFA received from breast milk were, on average,
lower than this threshold. However, the moderating effect
of average breastfeeding duration was not a statistically ro-
bust finding and could be due to chance, especially given
the large number of moderators evaluated in the meta-
regression analysis.
The strengths of our study include: appropriate sample
size for the primary analysis29; publication of the study
protocol,29 which helps to avoid biased reporting; analyses
Table 4. Meta-analytical linear regression coefficients (b) of the interaction term between FADS2 rs174575 or rs1535 genotypes
(recessive effect) with breastfeeding (never¼0; ever¼ 1), having maternal education (in complete years) or maternal cognitive
measures (in standard deviation units) as the outcome
SNP Outcome Model Number of Fixed effects meta-analysis Random effects meta-analysis
Estimates Subjects b 95% CI P-value b 95% CI P-value I2 (%)
rs174575 Maternal Unadjusted 7 14 671 0.28 0.11; 0.66 0.159 0.59 0.72; 1.91 0.375 81.1
education Adjusted (1)a 7 12 113 0.16 0.31; 0.62 0.509 0.16 0.45; 0.78 0.607 14.1
Maternal Unadjusted 5 6299 0.10 0.10; 0.31 0.326 0.10 0.13; 0.33 0.389 18.1
cognition Adjusted (1)a 5 6126 0.02 0.25; 0.21 0.854 0.02 0.25; 0.21 0.854 0.0
rs1535 Maternal Unadjusted 8 15 447 0.05 0.38; 0.28 0.784 0.04 0.39; 0.31 0.814 1.4
education Adjusted (1)a 8 12 743 0.12 0.51; 0.27 0.540 0.12 0.51; 0.27 0.540 0.0
Maternal Unadjusted 5 6556 0.10 0.08; 0.28 0.272 0.10 0.08; 0.28 0.272 0.0
cognition Adjusted (1)a 5 6378 0.14 0.05; 0.33 0.160 0.14 0.05; 0.33 0.160 0.0
nestimates, number of estimates being pooled; nsubjects , pooled sample size.
aCovariates were sex, age (linear and quadratic terms), ancestry-informative principal components (if available) and genotyping centre (if necessary).
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performed using standardized analysis scripts and datasets
harmonized as much as possible; inclusion of published
and unpublished reports, thus minimizing publication bias;
several a priori defined secondary and sensitivity analyses;
proper adjustment for covariates in the GE setting; and
IQ measures with similar variances, which reduces hetero-
geneity that could arise due to Z score conversion.53,54
Our study also had limitations. Some of them relate to
the small numbers of individuals in some categories, which
we addressed by adapting the protocol, such as by
re-defining the ‘never breastfed’ group and by excluding
some categories of breastfeeding from the analysis (see
Supplementary Methods, available as Supplementary data at
IJE online for detailed descriptions of all adaptations in the
protocol). Other limitations were: small sample size for some
analyses, such as those involving exclusive breastfeeding; het-
erogeneity in important study characteristics, such as age (in-
cluding pooling children and adult studies), type of IQ test
and timing of breastfeeding measurement; and small number
of studies in the meta-regression analyses. Another potential
limitation was lack of adjustment for maternal genotypes,
which may confound the association between participant’s
genotype and IQ because maternal genotypes may influence
fatty acid composition in breast milk.28 However, although
there is evidence that this may be the case for some genetic
variants implicated in LC-PUFA metabolism,28 previous
studies found no strong evidence that maternal genotypes
(rs174575 and rs1535) were associated with offspring’s IQ
or that maternal genotypes interact with breastfeeding.14,18
It is also possible that there are epistatic (i.e. gene-gene inter-
action) relationships between genes implicated in this path-
way. This could mean that focusing only on two variants in
a single gene may not capture the whole complexity of the
interplay between breastfeeding and genetic influences of
LC-PUFA levels on cognitive development.
Another potential limitation is the fact that non-breastfed
individuals may have received formula fortified with LC-
PUFAs. This could attenuate the GE interaction coefficient
even if the nutritional adequacy hypothesis is true, because
LC-PUFA requirements are being achieved through formula.
However, as shown in Table 4, the majority of the individu-
als included in the primary analysis were born before the
year 2000, and widespread LC-PUFAs fortification began in
the early 2000s.55 Moreover, mean birth year did not sub-
stantially explain between-study heterogeneity. Finally, sim-
ply adding nutrients present in breast milk to formula does
not necessarily mimic the biological effects of such nutrients
in breast milk,56 because the benefits of the latter depend on
a complex balance between its various components.1
A final limitation of our study is lack of power to detect
GE coefficients of relevant magnitude (Supplementary
Table 15, available as Supplementary data at IJE online). We
believe there are three main reasons for this. One of them is
substantial between-study heterogeneity, which was miti-
gated both by design (e.g. only individuals of European an-
cestry measured using standard tests were included) and
analysis (harmonized data preparation and analysis), but
could not be fully eliminated (as described above). There is a
trade-off between heterogeneity and sample size, and in the
case of this study, including further restrictions in the eligibil-
ity criteria would be prohibitive. The second is overestima-
tion of the GE coefficient in the sample size calculations,
where we used the point estimate reported by Steer et al.,14
which is the largest previous study on this topic, as the most
likely value. The point estimate from our primary analysis
(fully adjusted model) involving the rs174575 variant was
about half of Steer and colleagues’ result. Finally, our meta-
regression results indicate that coding breastfeeding into a
never vs ever variable is unlikely to be appropriate, which
might also have contributed to power loss. Given these power
issues, our most robust conclusion is that the ‘nullifying’ ef-
fect of the G-allele on the association between breastfeeding
and IQ is unlikely to exist, given that breastfeeding was posi-
tively associated with IQ in both genetic groups (Table 1).
Although our primary findings were not supportive of an
interaction between breastfeeding and FADS2 polymor-
phisms, random effects meta-regression results suggest that a
modified form of such interaction may exist, because studies
with longer average breastfeeding duration generally pre-
sented stronger positive estimates. Given the aforementioned
limitations of the meta-regression analysis, such interaction
should be investigated in future studies comparing different
categories of breastfeeding duration rather than simply never
vs ever comparisons (or other categorizations used here).
Since such analysis would involve many subgroupings, the
best alternative would likely be to perform them in a large
dataset of individual-level data, which may be achieved by a
consortium-based effort such as this collaborative meta-
analysis. This and other future investigations will be impor-
tant to further refine our understanding on the role of
LC-PUFAs on the association between breastfeeding and intel-
ligence. This will also have practical implications, such as
identifying whether current breastfeeding recommendations
provide for the upper limit of cognitive benefits related to LC-
PUFAs intake (if such limit exists), and the potential benefits
(if any) of supplementing a lactating infant with LC-PUFAs.
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